Shexiang Baoxin Pills as an Adjuvant Treatment for Chronic Heart Failure: A System Review and Meta-Analysis

Shexiang Baoxin Pills as an Adjuvant Treatment for Chronic Heart Failure: A System Review and Meta-Analysis

Background. Shexiang Baoxin pills (SXBXP), as a Traditional Chinese Medicine, are widely used for chronic heart failure in China. It is essential to systematically assess the efficacy and safety of SXBXP as an adjuvant treatment for chronic heart failure. Methods. Seven English and Chinese electroni...

Full description

Bibliographic Details
Main Authors:	Taiwei Dong, Jian Wang, Xiao Ma, Rong Ma, Jianxia Wen, Nian Chen, Qian Xie
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2018/6949348

Similar Items

Shexiang Baoxin Pills for Coronary Heart Disease in Animal Models: Preclinical Evidence and Promoting Angiogenesis Mechanism
by: Ke-Jian Zhang, et al.
Published: (2017-06-01)

Antidepressant and anxiolytic effects of the proprietary Chinese medicine Shexiang Baoxin pill in mice with chronic unpredictable mild stress
by: Xi-Dan Zhou, et al.
Published: (2019-01-01)

Protective Effect of Shexiang Baoxin Pill on Myocardial Ischemia/Reperfusion Injury in Patients With STEMI
by: Haixia Qin, et al.
Published: (2021-09-01)

Exploring the pathways and targets of Shexiang Baoxin pill for coronary heart disease through a network pharmacology approach
by: Shou-De Zhang, et al.
Published: (2018-01-01)

Co-administration of Shexiang Baoxin Pill and Chemotherapy Drugs Potentiated Cancer Therapy by Vascular-Promoting Strategy
by: Liu-qing Yang, et al.
Published: (2019-05-01)

Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria
by: Dan Wei, et al.
Published: (2018-03-01)

Metabolomic Strategy for Studying the Intervention and the Synergistic Effects of the Shexiang Baoxin Pill for Treating Myocardial Infarction in Rats
by: Li Xiang, et al.
Published: (2013-01-01)

Shexiang Baoxin Pill, Derived From the Traditional Chinese Medicine, Provides Protective Roles Against Cardiovascular Diseases
by: Li Lu, et al.
Published: (2018-11-01)

Shexiang Baoxin Pill, a Traditional Chinese Herbal Formula, Rescues the Cognitive Impairments in APP/PS1 Transgenic Mice
by: Wei-Hui Hu, et al.
Published: (2020-07-01)

Shexiang Baoxin Pill Alleviates the Atherosclerotic Lesions in Mice via Improving Inflammation Response and Inhibiting Lipid Accumulation in the Arterial Wall
by: Li Lu, et al.
Published: (2019-01-01)

Block Matching Pyramid Algorithm-Based Analysis on Efficacy of Shexiang Baoxin Pills Guided by Echocardiogram (ECG) on Patients with Angina Pectoris in Coronary Heart Disease
by: Junqing Gao, et al.
Published: (2021-01-01)

Shexiang Baoxin Pills Inhibited Proliferation and Migration of Human Coronary Artery Smooth Muscle Cells via PI3K/AKT/mTOR Pathway
by: Lei Hua, et al.
Published: (2021-08-01)

Shexiang Baoxin Pill, a Formulated Chinese Herbal Mixture, Induces Neuronal Differentiation of PC12 Cells: A Signaling Triggered by Activation of Protein Kinase A
by: Miranda Li Xu, et al.
Published: (2019-10-01)

Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial
by: Jun-Bo Ge, et al.
Published: (2021-01-01)

Shexiang Baoxin Pill, a Proprietary Multi-Constituent Chinese Medicine, Prevents Locomotor and Cognitive Impairment Caused by Brain Ischemia and Reperfusion Injury in Rats: A Potential Therapy for Neuropsychiatric Sequelae of Stroke
by: Zong-Shi Qin, et al.
Published: (2021-04-01)

Preclinical Evidence and Mechanism of Xingnaojing Injection for Cerebral Ischemia: A Systematic Review and Meta-Analysis of Animal Studies
by: Rong Ma, et al.
Published: (2018-01-01)

Shexiang-Wulong Pills Attenuate Rheumatoid Arthritis by Alleviating Inflammation in a Mouse Model of Collagen-Induced Arthritis
by: Zhihui Zhang, et al.
Published: (2019-01-01)

Effect of Qishen Yiqi dripping pills combined with trimetazidine on the treatment of chronic heart failure: A meta-analysis
by: Feng Xie, et al.
Published: (2021-05-01)

Shexiang Tongxin Dropping Pill combined with thrombus aspiration improves myocardial perfusion after PCI in patients with STEMI: the clinical research
by: Shan-Shan Xiao, et al.
Published: (2017-04-01)

Efficacy of Qishen Yiqi Drop Pill for Chronic Heart Failure: An Updated Meta-Analysis of 85 Studies
by: Hao Wang, et al.
Published: (2020-01-01)

Qualitative and Quantitative Analysis of the Major Constituents in Shexiang Tongxin Dropping Pill by HPLC-Q-TOF-MS/MS and UPLC-QqQ-MS/MS
by: Daxin Chen, et al.
Published: (2015-10-01)

Qishen Yiqi dripping pills for chronic ischaemic heart failure: results of the CACT‐IHF randomized clinical trial
by: Jingyuan Mao, et al.
Published: (2020-12-01)

Clinical Efficacy and Safety of Qishen Yiqi Dropping Pill Combined with Conventional Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis
by: Lisheng Chen, et al.
Published: (2021-01-01)

BAOXIN Granules Protected Mouse Model With Elevated Afterload From Cardiac Hypertrophy by Suppressing Both Inflammatory Reaction and Collagen Deposition
by: Xu Qiu, et al.
Published: (2019-07-01)

Clinical Efficacy and Safety of Xinmailong Injection for the Treatment of Chronic Heart Failure: A Meta-Analysis
by: Xiaohua Lu, et al.
Published: (2018-07-01)

Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
by: Mengxi Wang, et al.
Published: (2021-02-01)

Investigating the Pharmacological Mechanisms of SheXiang XinTongNing Against Coronary Heart Disease Based on Network Pharmacology and Experimental Evaluation
by: Li-ying Jia, et al.
Published: (2021-07-01)

Effect of adjuvant levosimendan therapy on neuroendocrine hormones and cytokines in elderly patients with chronic heart failure
by: Li Lei, et al.
Published: (2017-11-01)

Pill Properties that Cause Dysphagia and Treatment Failure
by: Jeremy Fields, MD, et al.
Published: (2015-12-01)

Effect of Xinyi Biyan Pill in Adjuvant Treatment of Patients with Chronic Rhinosinusitis and Its Influence on Serum Inflammatory Factors and Immune Function
by: Qingfu Bao, et al.
Published: (2021-01-01)

Adjuvant Use of Ivabradine in Acute Heart Failure due to Myocarditis
by: Jennifer Franke, et al.
Published: (2011-01-01)

Efficacy of Suxiao Jiuxin Pill on Coronary Heart Disease: A Meta-Analysis of Randomized Controlled Trials
by: Li Ren, et al.
Published: (2018-01-01)

Effects of Yoga in Patients with Chronic Heart Failure: A Meta-Analysis
by: Mansueto Gomes-Neto, et al.
Published: (2014-11-01)

Chinese Herbal Medicines and Conventional Chronic Heart Failure Treatment for the Management of Chronic Heart Failure Complicated with Depression: A Systematic Review and Meta-Analysis
by: Peidan Yang, et al.
Published: (2020-01-01)

Dapagliflozin in Patients with Chronic Heart Failure: A Systematic Review and Meta-Analysis
by: Ru-ping Cai, et al.
Published: (2021-01-01)

Bone mineral density in patients with chronic heart failure: a meta-analysis
by: Xing WM, et al.
Published: (2018-02-01)

ADDITIONAL USE OF TRIMETAZIDINE IN PATIENTS WITH CHRONIC HEART FAILURE. A META-ANALYSIS
by: Lei Zhang, et al.
Published: (2015-12-01)

ADDITIONAL USE OF TRIMETAZIDINE IN PATIENTS WITH CHRONIC HEART FAILURE. A META-ANALYSIS
by: Lei Zhang, et al.
Published: (2015-12-01)

Metabolomics coupled with integrated approaches reveal the therapeutic effects of higenamine combined with [6]-gingerol on doxorubicin-induced chronic heart failure in rats
by: Jianxia Wen, et al.
Published: (2020-11-01)

Effect of the adjuvant milrinone therapy on cardiac function, myocardial remodeling and RAAS system activity in patients with chronic heart failure
by: Jing Chen
Published: (2017-09-01)